Merck & Company: Evaluating a Drug Licensing Opportunity

Abstract

Spreadsheet to (9-201-023). Download only.

Ruback, Richard S. "Merck & Company: Evaluating a Drug Licensing Opportunity." Harvard Business School Spreadsheet Supplement 201-707, June 2001.

Finance

- June 2020
- Faculty Research
gWorks

By: Richard S. Ruback and Royce Yudkoff
- May 2020
- Faculty Research
Talismark

By: Richard S. Ruback, Royce Yudkoff and Ahron Rosenfeld
- May 2020
- Faculty Research
Baskits Inc.

By: Richard S. Ruback, Royce Yudkoff and Ahron Rosenfeld